Phibro Animal Stock Price, News & Analysis

Phibro Animal Health Corporation (Nasdaq:PAHC) reported strong financial results for its second quarter ending December 31, 2021, highlighting net sales of $233 million, a 13% increase from the previous year. Net income rose to $17 million, up 36%, with diluted EPS increasing to $0.43, a 34% rise. The company also revised its full-year net sales guidance upward to $890-$920 million. Key revenue drivers included improved demand in Animal Health and Mineral Nutrition segments, despite challenges from rising costs and supply chain issues. Adjusted EBITDA was reported at $29 million.

The Board of Directors of Phibro Animal Health Corporation (NASDAQ: PAHC) declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. This dividend will be payable on March 23, 2022, to stockholders of record as of March 2, 2022. Phibro is a global leader in developing animal health and mineral nutrition products, aiding farmers and veterinarians in producing affordable food sustainably.

Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the BofA Securities 2022 Virtual Animal Health Summit on February 24, 2022, at 12:40 PM ET. CFO Damian Finio and EVP Daniel Bendheim will present to financial analysts and investors. The session will be available live on the company's Investor Relations Website, with a replay archived afterward. Phibro focuses on providing a wide range of animal health and mineral nutrition products, supporting sustainable food production.

Phibro Animal Health Corporation (NASDAQ: PAHC) announced that the FDA will hold a public hearing on March 10, 2022, regarding its product Mecadox® (carbadox). This antibiotic has been used in the U.S. for 50 years to control bacterial diseases in swine. The FDA seeks data on the product's safety, following past concerns about carcinogenic residues. Phibro has been proactively providing research to confirm the product's safety, stating that it will defend its continued market availability. They anticipate the hearing will support the safe use of Mecadox.

Phibro Animal Health Corporation (NASDAQ:PAHC) is set to announce its second quarter financial results on February 9, 2022, after market close. A conference call and webcast will follow on February 10, 2022, at 9:00 AM ET. Interested parties can join via the company's investor relations website or by calling provided numbers. Phibro develops and supplies a range of animal health products, promoting sustainable livestock management and food production. For more details, visit www.pahc.com.

Phibro Animal Health Corporation (NASDAQ:PAHC) announced its participation in the 4th Annual Evercore ISI Virtual Conference on December 1, 2021, at 8:00 AM ET. Chief Financial Officer Damian Finio and Executive Vice President Daniel Bendheim will present to financial analysts and investors. Participants can access the live audio presentation on the Phibro Investor Relations Website, and a replay will be archived for later listening. Phibro is a global developer and supplier of animal health and mineral nutrition products aimed at supporting sustainable food production.

Phibro Animal Health Corporation (Nasdaq: PAHC) reported its Q1 financial results for the period ending September 30, 2021. Net sales increased by 10% to $215 million, while net income dropped 47% to $7 million. Diluted EPS fell by 47% to $0.16. The company raised its fiscal year net sales guidance to $860-$890 million, citing strong product demand, especially in nutritional specialties and vaccines, despite challenges from increased costs. Gross profit margins decreased to 30.1%. The outlook includes further price adjustments to offset rising freight costs.

The Board of Directors of Phibro Animal Health Corporation (NASDAQ:PAHC) has declared a quarterly cash dividend of $0.12 per share on its Class A and Class B common stock. This dividend will be payable on December 15, 2021, to stockholders of record as of the close of business on November 24, 2021. Phibro is a global developer and supplier of animal health and mineral nutrition products, aimed at supporting livestock health and sustainability.

Phibro Animal Health Corporation (NASDAQ: PAHC) will release its first quarter financial results on November 2, 2021, after market close. A conference call and webcast are scheduled for November 3, 2021, at 9:00 AM ET. Investors can access the presentation through the company’s investor relations website. This event is expected to provide key insights into the company's financial performance and future guidance, an important aspect for stakeholders.